Skip to content
Expert Rising

Pilot Program Terms and Conditions

Last Updated:

Expert Rising Incorporated, a Delaware corporation (“Company”), has developed a web-accessible software platform designed to enhance medical learning and knowledge retention through personalized educational tools and continuing medical education (“CME”) resources, and known in the marketplace as Expert Rising™ (the “Platform”). You have requested the right to access and use the Platform on a limited, evaluation-only basis during and in connection with a beta testing and/or pilot program period designated by Company (the “Trial Period”). The following Pilot Program Terms and Conditions (these “Terms and Conditions”) govern your access to and use of the Platform and related documentation during the Trial Period. You and the Company agree as follows:

1. Acceptance

Please read these Terms and Conditions carefully before you start to use the Platform. BY USING THE PLATFORM, AND/OR BY CLICKING TO ACCEPT OR AGREE TO THESE TERMS AND CONDITIONS WHEN THIS OPTION IS MADE AVAILABLE TO YOU, YOU ACCEPT AND AGREE TO BE BOUND AND ABIDE BY THESE TERMS AND CONDITIONS. If you do not want to agree to these Terms and Conditions, then you must not access or use the Platform.

2. Eligibility; User Representations and Warranties

The Platform is offered and available only to users who are of the age of majority in the relevant jurisdiction (e.g., 18 years of age or older in most jurisdictions) and who reside and are located in the United States. The Platform may not be accessed or used by any person or entity located outside of the United States. By using the Platform, and/or by clicking to accept or agree to these Terms and Conditions when this option is made available, you represent and warrant to Company that you meet all of the foregoing eligibility requirements and that all registration information you provide is true, accurate and complete. If you do not meet any or all of these requirements, then you must not access or use the Platform.

3. Changes to the Terms and Conditions

Company may revise and update these Terms and Conditions from time to time in its sole discretion. Changes are effective immediately when Company posts them, but are not retroactive. Your continued use of the Platform following the posting of revised Terms and Conditions means that you accept and agree to the changes. You must check this page frequently so that you are aware of any changes, and immediately discontinue access or use of the Platform if you do not want to agree to the revised Terms and Conditions.

4. Right to Use

Subject to these Terms and Conditions, Company grants you the right, on a limited, non-exclusive, non-transferable, non-sublicensable and fully revocable basis during the Trial Period, to: (a) access and use the Platform remotely over the Internet; and (b) access and use the user manuals, guides and other written documentation concerning the Platform made available to you by Company (the “Documentation”), in each case solely for purposes of participating in the pilot program involving the Platform, for your personal, non-commercial educational self-assessment, and otherwise for your evaluation of the Platform to determine if you want to purchase further subscription rights to the Platform pursuant to a definitive agreement with Company (the “Permitted Use”).

5. Right to Withdraw, Amend or Restrict Access

Company reserves the right to withdraw or amend the Platform, and any features, functionality, content or data Company provides on the Platform, in its sole discretion without notice. Additionally, from time to time, Company may restrict access to some parts of the Platform, or the entire Platform, to certain select users, in Company’s sole discretion without notice. Company will not be liable if, for any reason, all or any part of the Platform is unavailable at any time or for any period.

6. Limitations

You must not use the Platform or Documentation for any purpose other than the Permitted Use or otherwise beyond the scope of the rights granted in these Terms and Conditions, and you must use commercially reasonable efforts to prevent unauthorized access to or use of the Platform. Without limiting the foregoing and except as otherwise expressly set forth in these Terms and Conditions, you must not (and you must not permit any other person or entity to), directly or indirectly: (a) copy, record, screenshot, reproduce, compile, modify, adapt, translate or create derivative works or improvements of the Platform or any portion thereof, including any associated features, functionality, software, content, questions, answers, explanations, assessments, recommendations, materials and services made available on or through the Platform by Company, including any new versions, updates, revisions, derivative works, improvements and modifications of the foregoing, and including the look and feel, ideas, algorithms, methods and concepts underlying or embedded in any of the foregoing (collectively, and including the Documentation, the “Company IP”); (b) rent, lease, lend, sell, sublicense, assign, distribute, publish, share, transfer or otherwise make available the Company IP to any person or entity for any reason, including by making the Platform available through any time-sharing, service bureau or software-as-a-service arrangement, or use the Platform in production or to provide services to or for the benefit of any third party; (c) share your access credentials with, or permit use of your access credentials by, any other person or entity, or fail to notify Company promptly upon becoming aware of any unauthorized access to or use of your account or access credentials or any other breach of security; (d) reverse engineer, disassemble, decompile, decode, adapt, or otherwise attempt to derive or gain access to the source code of the Platform or the underlying structure, ideas, know-how, algorithms or methodology relevant to the Company IP; (e) bypass, breach or disable any security device, copy control or other protection used by the Platform, attempt to gain unauthorized access to, or damage, disrupt, impair or interfere with, the Platform or any server, computer or database connected to it, or impose an unreasonable or disproportionately large load on the Platform, as reasonably determined by Company; (f) use the Platform or the Company IP in any manner that violates any applicable law or regulation or infringes, misappropriates or otherwise violates any intellectual property right, privacy right or other right of any person or entity, including by inputting, uploading or transmitting to or through the Platform (i) any information or materials that are infringing, defamatory, fraudulent or otherwise unlawful, (ii) any virus, malware or other malicious code, or (iii) any data that you are not authorized to share under applicable law or your obligations to third parties; (g) upload or submit to the Platform any information about your patients, including any protected health information, or any other personally identifiable information of any individual other than your own information requested by the Platform; (h) remove, obscure or alter any intellectual property right or confidentiality notices or legends appearing in or on any aspect of the Company IP; (i) impersonate any other person or entity or misrepresent your identity, credentials or affiliation with any other person or entity; (j) access or use the Platform for purposes of developing, producing, marketing or selling any product or service that may compete with the Platform, competitive analysis, or disclosing to Company’s competitors any non-public information about the Platform; (k) except as expressly permitted by Company in writing, access or use the Platform, or scrape, mine or extract any data or content from the Platform, using any robot, spider, scraper, artificial intelligence agent or other automated means, or using any means to mask, spoof or otherwise obscure your IP address or identity; (l) publish or disclose to any third party any performance data, benchmarks or results of any testing or evaluation of the Platform without Company’s prior written consent; or (m) knowingly assist any other person or entity in taking any of the actions prohibited by this Section.

7. Ownership

You acknowledge that Company owns all right, title and interest, including all intellectual property rights, in and to the Company IP. Except for the limited rights expressly granted under these Terms and Conditions, nothing in these Terms and Conditions grants to you any intellectual property rights or other right, title or interest in or to the Company IP, and Company reserves all rights not expressly granted to you in these Terms and Conditions.

8. Beta Version

You acknowledge and agree that the Platform is provided in beta form, is not a final production product, and may contain bugs, errors, design flaws, inaccuracies or other problems (“Errors”), and that the existence of Errors shall not be considered a breach or default under these Terms and Conditions. Company will use commercially reasonable efforts to correct Errors within a commercially reasonable time, but if Company concludes that correcting any Error is not feasible within commercially reasonable standards, Company may immediately terminate these Terms and Conditions and withdraw the Platform.

9. Educational Purposes Only; No Medical Advice; Reliance on Information

The Platform and all questions, answers, explanations, assessments, recommendations and other information made available on or through the Platform are provided solely for general educational and informational purposes. The Platform does not provide medical advice and is not intended to be used for, and must not be relied upon for, the diagnosis or treatment of any patient or as a substitute for your independent professional medical judgment. Your assessment results are intended only to support your own self-directed learning and are not a certification or evaluation of your professional competence. Although Company endeavors to base Platform content on recently published and reputable sources, medical knowledge and standards of care change rapidly, and Company does not warrant the accuracy, completeness, timeliness or usefulness of any information presented on or through the Platform. Any reliance you place on such information is strictly at your own risk. Company disclaims all liability and responsibility arising from any reliance placed on such information or materials by you or any other user of the Platform, or by anyone who may be informed of any of its contents. Company does not accredit, sponsor or endorse any third-party CME content recommended through the Platform, does not grant, accredit or report CME credit for any such content, and your access to and use of any such third-party content is subject solely to the terms and conditions of the applicable third party.

10. Disclaimer; Limitation of Liability

EXCEPT AS EXPRESSLY SET FORTH IN SECTION 8, THE PLATFORM, ALL SERVICES AND ALL COMPANY IP ARE PROVIDED “AS IS” AND “AS AVAILABLE” WITHOUT SUPPORT OR WARRANTY OF ANY KIND, AND COMPANY HEREBY DISCLAIMS ALL WARRANTIES, WHETHER EXPRESS, IMPLIED, STATUTORY OR OTHERWISE, INCLUDING ALL IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, TITLE, NON-INFRINGEMENT AND ACCURACY, AND ALL WARRANTIES ARISING FROM COURSE OF DEALING, USAGE OR TRADE PRACTICE. WITHOUT LIMITING THE FOREGOING, COMPANY MAKES NO WARRANTY THAT THE PLATFORM WILL MEET YOUR REQUIREMENTS, OPERATE WITHOUT INTERRUPTION OR ERROR, OR THAT ANY CONTENT OR RECOMMENDATIONS WILL BE ACCURATE, COMPLETE OR CURRENT. IN NO EVENT WILL COMPANY BE LIABLE UNDER OR IN CONNECTION WITH THESE TERMS AND CONDITIONS FOR ANY INDIRECT, INCIDENTAL, CONSEQUENTIAL, SPECIAL, EXEMPLARY OR PUNITIVE DAMAGES, OR FOR ANY LOSS OF PROFITS, REVENUE, DATA OR GOODWILL, OR ANY CLAIM ARISING FROM ANY CLINICAL OR PATIENT-CARE DECISION, IN EACH CASE REGARDLESS OF WHETHER COMPANY WAS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. COMPANY’S AGGREGATE LIABILITY TO YOU OR ANY OTHER PERSON OR ENTITY UNDER OR IN CONNECTION WITH THESE TERMS AND CONDITIONS OR IN ANY WAY RELATED TO THE PROVISION OF THE PLATFORM, ANY SERVICES OR COMPANY IP SHALL NOT EXCEED ONE HUNDRED DOLLARS UNDER ANY CIRCUMSTANCES.

11. Confidentiality

(a) General. During the Trial Period, each party (the “Discloser”) may disclose proprietary or confidential information (“Confidential Information”) to the other party (the “Recipient”). During the Trial Period and thereafter, the Recipient will not, without the Discloser’s written consent, disclose the Discloser’s Confidential Information to third parties or use the Discloser’s Confidential Information except as permitted by these Terms and Conditions or to carry out its obligations or exercise its rights hereunder. Non-public information related to the Platform and the Company IP, including the questions, answers and other assessment content and the features, functionality and performance of the Platform, is Company’s Confidential Information; your individual, identifiable assessment results are your Confidential Information, subject to Company’s rights under Section 13; and the terms of these Terms and Conditions are both parties’ Confidential Information. (b) Exceptions. These restrictions do not apply to information that (i) is or becomes publicly known through no fault of the Recipient, (ii) is lawfully received from a third party not under confidentiality obligations to the Discloser, or (iii) was rightfully known by the Recipient before receipt from the Discloser. The Recipient may also disclose Confidential Information as legally compelled by law or court order, provided the Recipient first gives the Discloser reasonable prior notice to permit a challenge to such disclosure.

12. Feedback

You may (but you are not obligated to) provide Company suggestions, comments, recommendations, survey responses or other feedback relating to the Platform or other Company offerings (“Feedback”). You hereby grant to Company a perpetual, irrevocable, non-exclusive, royalty-free and fully paid, sublicensable (through multiple tiers), transferable, worldwide license to use, reproduce, modify, distribute, and create derivative works of Feedback for any purpose, subject to the Privacy Policy with respect to any Personal Information (as defined in the Privacy Policy) included in Feedback. Company has the right, but not the obligation, to use Feedback in any way without attribution, accounting, compensation, or other obligation to you. You acknowledge that any Feedback is provided voluntarily and without expectation of compensation or confidential treatment.

13. Usage Data; Privacy Policy; Publication of Aggregated Results

You acknowledge that Company may collect data regarding your registration, access to and use of the Platform, including your responses and assessment results (“Usage Data”). All information Company collects through or in connection with the Platform, including Usage Data, is subject to Company’s Privacy Policy (available at Privacy Policy) (the “Privacy Policy”), which is incorporated into these Terms and Conditions by reference. By accessing and using the Platform and providing information about yourself to or through the Platform, you consent to all actions taken by Company with respect to your information in compliance with the Privacy Policy. You agree that Company may use Usage Data to operate, maintain, improve and develop the Platform, and may de-identify, aggregate and anonymize Usage Data and Feedback so that it does not identify you (“Aggregated Data”). Subject to the Privacy Policy, Company may use, disclose and publish Aggregated Data for any lawful purpose, including to train and improve Company’s own models, to provide group-level reports to organizations that partner with Company on pilot programs, and in studies, articles or presentations regarding the effectiveness of the Platform and its underlying algorithms and technology. Company will not publish your individual, identifiable assessment results or share them with any third party unless you have affirmatively opted in to such publication or sharing as described in the Privacy Policy.

14. Term and Termination

These Terms and Conditions begin when first accepted by you in accordance with Section 1 above and continue until terminated in accordance with this Section. Either party may terminate these Terms and Conditions at any time, for any reason or for no reason, immediately upon written notice to the other party, which, in the case of Company, may be provided by notice posted on the Platform. In addition, these Terms and Conditions and your right to access and use the Platform and the Company IP shall terminate immediately, without any notice or additional action on the part of Company, if you breach or violate these Terms and Conditions. Upon expiration or termination of these Terms and Conditions, all rights granted by a party to the other shall immediately terminate and you must immediately cease all access to and use of the Company IP. Sections 6, 7, 9, 10, 11, 12, 13, 14 and 15 shall survive any expiration or termination of these Terms and Conditions.

15. Miscellaneous

Neither party may issue any announcement, press release or other publicity relating to these Terms and Conditions or use the other party’s name, trademarks or logos without the other party’s prior written consent. These Terms and Conditions constitute the entire agreement of the parties with respect to their subject matter and supersede all prior and contemporaneous understandings, agreements, representations and warranties, whether written or oral. All notices to Company under these Terms and Conditions must be in writing and sent by email to privacy@expertrising.com, and Company may provide notices to you by email to the email address associated with your account or by posting notice on the Platform. You may not assign, delegate or otherwise transfer any of your rights or obligations under these Terms and Conditions without Company’s prior written consent, and any purported assignment, delegation or transfer in violation of this sentence is void; Company may assign these Terms and Conditions in their entirety without your consent to its affiliates or to any successor to all or substantially all of the business or assets of Company. These Terms and Conditions are binding upon, and inure to the benefit of, the parties and their respective successors and permitted assigns. Except as provided in Section 3, no amendment, modification or termination of these Terms and Conditions is effective unless in writing and signed by each party. No waiver is effective unless in writing and signed by the waiving party, and no failure or delay in exercising any right, remedy, power or privilege will operate as a waiver of it or preclude any further exercise of it or any other right, remedy, power or privilege. If any provision of these Terms and Conditions is invalid, illegal or unenforceable in any jurisdiction, that will not affect any other provision or render that provision invalid or unenforceable in any other jurisdiction. These Terms and Conditions are governed by the laws of the State of Delaware, excluding its choice of law rules. Any legal suit, action or proceeding arising out of or related to these Terms and Conditions or the Platform shall be instituted exclusively in the state or federal courts located in Columbia, South Carolina, and each party irrevocably submits to the exclusive jurisdiction of such courts and waives any objection to venue in such courts, including any objection based on inconvenient forum.